NCNA NuCana plc

Nasdaq nucana.com


$ 4.23 $ 0.17 (4.23 %)    

Thursday, 23-Oct-2025 15:59:50 EDT
QQQ $ 611.70 $ 5.09 (0.84 %)
DIA $ 467.20 $ 1.51 (0.32 %)
SPY $ 672.21 $ 3.96 (0.59 %)
TLT $ 91.38 $ -0.63 (-0.68 %)
GLD $ 378.90 $ 1.51 (0.4 %)
$ 4.19
$ 3.97
$ 3.90 x 1
$ 4.50 x 1,000
-- - --
$ 2.78 - $ 379.62
96,852
na
2.98M
$ 1.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-saturday-nucana-highlights-synergy-between-nuc-7738-and-pd-1-inhibitors-in-rcc-organoids-supporting-expansion-of-nutide701-clinical-study

NUC-7738 Synergizes with PD-1 Inhibitors to Promote Cancer Cell DeathData Reinforces Mechanism of Action along with Efficacy an...

 nucana-publishes-nutide303-clinical-and-preclinical-data-on-nuc-3373-in-medrxiv-and-plos-one

NUC-3373 Plus Pembrolizumab Continues to Show Favorable Efficacy and Safety Profile in Heavily Pre-treated PatientsLatest Data ...

 nucana-cancels-all-remaining-series-a-warrants-after-raising-required-capital-eliminating-overhang-from-may-2025-offering

NuCana plc (NASDAQ:NCNA) ("NuCana" or the "Company") announces it has successfully canceled all remaining Serie...

 nucana-announces-1-for-200-ads-ratio-change-effective-august-8-2025

NuCana plc (NASDAQ:NCNA) ("NuCana" or the "Company") announced plans to change the ratio of its American Deposi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION